{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:05:57Z","timestamp":1787497557663,"version":"build-2736575974"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.leukres.2021.106607","type":"journal-article","created":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T11:39:10Z","timestamp":1619782750000},"page":"106607","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Pretreatment whole blood Epstein-Barr virus DNA predicts prognosis in Hodgkin lymphoma"],"prefix":"10.1016","volume":"107","author":[{"given":"Jia-Qi","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Zhu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-Ze","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua-Yuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Yong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Hua","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4208-7477","authenticated-orcid":false,"given":"Wei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.leukres.2021.106607_bib0005","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/S1470-2045(09)70358-4","article-title":"A review of human carcinogens--part F: chemical agents and related occupations","volume":"10","author":"Baan","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.leukres.2021.106607_bib0010","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3389\/fonc.2019.00062","article-title":"EBV Viral Loads in Diagnosis, Monitoring, and Response Assessment","volume":"9","author":"Kimura","year":"2019","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.leukres.2021.106607_bib0015","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1182\/blood.V86.2.659.bloodjournal862659","article-title":"Heterogeneous expression of Epstein-Barr virus latent proteins in endemic Burkitt\u2019s lymphoma","volume":"86","author":"Niedobitek","year":"1995","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.leukres.2021.106607_bib0020","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1182\/blood.V88.1.242.242","article-title":"Epstein-Barr virus latent membrane protein-1 oncogene deletions: correlations with malignancy in Epstein-Barr virus--associated lymphoproliferative disorders and malignant lymphomas","volume":"88","author":"Kingma","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2021.106607_bib0025","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.3389\/fimmu.2017.01867","article-title":"Chronic active epstein-barr virus disease","volume":"8","author":"Kimura","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.leukres.2021.106607_bib0030","doi-asserted-by":"crossref","first-page":"iv19","DOI":"10.1093\/annonc\/mdy080","article-title":"Hodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Eichenauer","year":"2018","journal-title":"Ann. Oncol."},{"issue":"10","key":"10.1016\/j.leukres.2021.106607_bib0035","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S1470-2045(13)70341-3","article-title":"Effect of initial treatment strategy on survival of patients with advanced-stage Hodgkin\u2019s lymphoma: a systematic review and network meta-analysis","volume":"14","author":"Skoetz","year":"2013","journal-title":"Lancet Oncol."},{"issue":"2","key":"10.1016\/j.leukres.2021.106607_bib0040","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1158\/1078-0432.CCR-05-2008","article-title":"Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin\u2019s lymphoma","volume":"12","author":"Gandhi","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.leukres.2021.106607_bib0045","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens9030226","article-title":"Recent advances in diagnostic approaches for epstein-barr virus","volume":"9","author":"AbuSalah","year":"2020","journal-title":"Pathogens."},{"issue":"5","key":"10.1016\/j.leukres.2021.106607_bib0050","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1136\/mp.53.5.238","article-title":"The expression and function of Epstein-Barr virus encoded latent genes","volume":"53","author":"Young","year":"2000","journal-title":"Mol Pathol."},{"issue":"1","key":"10.1016\/j.leukres.2021.106607_bib0055","first-page":"239","article-title":"Quantitative analysis of circulating cell-free Epstein-Barr virus (EBV) DNA levels in patients with EBV-associated lymphoid malignancies","volume":"111","author":"Lei","year":"2000","journal-title":"Br. J. Haematol."},{"issue":"5","key":"10.1016\/j.leukres.2021.106607_bib0060","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/rmv.582","article-title":"Measuring Epstein-Barr virus (EBV) load: the significance and application for each EBV-associated disease","volume":"18","author":"Kimura","year":"2008","journal-title":"Rev. Med. Virol."},{"issue":"2","key":"10.1016\/j.leukres.2021.106607_bib0065","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00019606-200406000-00001","article-title":"Epstein-Barr Virus (EBV) DNA in plasma is not encapsidated in patients with EBV-related malignancies","volume":"13","author":"Ryan","year":"2004","journal-title":"Diagn. Mol. Pathol."},{"issue":"9","key":"10.1016\/j.leukres.2021.106607_bib0070","first-page":"2028","article-title":"Molecular characterization of circulating EBV DNA in the plasma of nasopharyngeal carcinoma and lymphoma patients","volume":"63","author":"Chan","year":"2003","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.leukres.2021.106607_bib0075","first-page":"4059","article-title":"Comparison of Epstein-Barr virus DNA level in plasma, peripheral blood cell and tumor tissue in nasopharyngeal carcinoma","volume":"24","author":"Shao","year":"2004","journal-title":"Anticancer Res."},{"issue":"16","key":"10.1016\/j.leukres.2021.106607_bib0080","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1182\/blood-2015-09-672030","article-title":"The clinical significance of EBV DNA in the plasma and peripheral blood mononuclear cells of patients with or without EBV diseases","volume":"127","author":"Kanakry","year":"2016","journal-title":"Blood."},{"issue":"5","key":"10.1016\/j.leukres.2021.106607_bib0085","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s00277-016-2610-5","article-title":"Pretreatment whole blood Epstein-Barr virus-DNA is a significant prognostic marker in patients with Hodgkin lymphoma","volume":"95","author":"Park","year":"2016","journal-title":"Ann. Hematol."},{"issue":"9","key":"10.1016\/j.leukres.2021.106607_bib0090","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1158\/1078-0432.CCR-10-3327","article-title":"The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma","volume":"17","author":"Hohaus","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.leukres.2021.106607_bib0095","series-title":"WHO Classifcation of Tumours of Haematopoietic and Lymphoid Tissues. World Health Organization Classifcation of Tumours","author":"Swerdlow","year":"2008"},{"key":"10.1016\/j.leukres.2021.106607_bib0100","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (Revised 4th edition)","author":"Swerdlow","year":"2017"},{"issue":"27","key":"10.1016\/j.leukres.2021.106607_bib0105","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.leukres.2021.106607_bib0110","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.cmi.2015.02.017","article-title":"Epstein-Barr virus (EBV) DNA in whole blood as a superior prognostic and monitoring factor than EBV-encoded small RNA in situ hybridization in diffuse large B-cell lymphoma","volume":"21","author":"Liang","year":"2015","journal-title":"Clin. Microbiol. Infect."},{"issue":"1","key":"10.1016\/j.leukres.2021.106607_bib0115","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4143\/crt.2017.476","article-title":"The Prognostic Role of Circulating Epstein-Barr Virus DNA Copy Number in Angioimmunoblastic T-Cell Lymphoma Treated with Dose-Adjusted EPOCH","volume":"51","author":"Liang","year":"2019","journal-title":"Cancer Res. Treat."},{"issue":"9","key":"10.1016\/j.leukres.2021.106607_bib0120","doi-asserted-by":"crossref","first-page":"e608","DOI":"10.1038\/bcj.2017.88","article-title":"Efficacy of pegaspargase, etoposide, methotrexate and dexamethasone in newly diagnosed advanced-stage extra-nodal natural killer\/T-cell lymphoma with the analysis of the prognosis of whole blood EBV-DNA","volume":"7","author":"Liang","year":"2017","journal-title":"Blood Cancer J."},{"issue":"13","key":"10.1016\/j.leukres.2021.106607_bib0125","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1056\/NEJMra032015","article-title":"Persistence of the Epstein-Barr virus and the origins of associated lymphomas","volume":"350","author":"Thorley-Lawson","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.leukres.2021.106607_bib0130","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1182\/blood-2008-06-164806","article-title":"Age-related Epstein-Barr virus (EBV)-associated B-cell lymphoproliferative disorders: comparison with EBV-positive classic Hodgkin lymphoma in elderly patients","volume":"113","author":"Asano","year":"2009","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.leukres.2021.106607_bib0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004656","article-title":"To be or not IIb: a multi-step process for Epstein-Barr virus latency establishment and consequences for B cell tumorigenesis","volume":"11","author":"Price","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.leukres.2021.106607_bib0140","doi-asserted-by":"crossref","DOI":"10.1038\/s41564-020-0724-y","article-title":"DNA methylation enzymes and PRC1 restrict B-cell Epstein-Barr virus oncoprotein expression","author":"Guo","year":"2020","journal-title":"Nat. Microbiol."},{"issue":"1","key":"10.1016\/j.leukres.2021.106607_bib0145","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/hon.2468","article-title":"Epstein-Barr virus positivity is associated with angiogenesis in, and poorer survival of, patients receiving standard treatment for classical Hodgkin\u2019s lymphoma","volume":"36","author":"Koh","year":"2018","journal-title":"Hematol. Oncol."},{"issue":"18","key":"10.1016\/j.leukres.2021.106607_bib0150","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1182\/blood-2012-09-454694","article-title":"Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma: correlative analysis from a large North American cooperative group trial","volume":"121","author":"Kanakry","year":"2013","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.leukres.2021.106607_bib0155","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1080\/10428194.2017.1300894","article-title":"The clinical significance of Epstein-Barr virus DNA in peripheral blood mononuclear cells in patients with non-Hodgkin lymphoma","volume":"58","author":"Chen","year":"2017","journal-title":"Leuk. Lymphoma"},{"issue":"10","key":"10.1016\/j.leukres.2021.106607_bib0160","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1182\/blood-2008-06-155820","article-title":"Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma","volume":"112","author":"Kobe","year":"2008","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.leukres.2021.106607_bib0165","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1093\/annonc\/mdp522","article-title":"Positron emission tomography at the end of first-line therapy and during follow-up in patients with Hodgkin lymphoma: a retrospective study","volume":"21","author":"Mocikova","year":"2010","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.leukres.2021.106607_bib0170","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1600-0463.2010.02685.x","article-title":"Plasma EBV-DNA monitoring in Epstein-Barr virus-positive Hodgkin lymphoma patients","volume":"119","author":"Spacek","year":"2011","journal-title":"APMIS"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212621001089?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212621001089?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T01:00:58Z","timestamp":1758934858000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212621001089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":34,"alternative-id":["S0145212621001089"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2021.106607","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pretreatment whole blood Epstein-Barr virus DNA predicts prognosis in Hodgkin lymphoma","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2021.106607","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106607"}}